Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Embecta Corporation (EMBC)
NASDAQ:EMBC
Holding EMBC?
Track your performance easily
EMBC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$9.93 - $21.48
Previous CloseN/A
Volume119.84K
Average Volume (3M)414.19K
Market Cap
$1.10B
Enterprise Value$2.17B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)14.1
Beta0.95
Next Earnings
Feb 18, 2025EPS Estimate
0.44Last Dividend Ex-Date
Dec 06, 2024Dividend Yield3.16%
Share Statistics
EPS (TTM)1.35
Shares Outstanding58,131,760
10 Day Avg. Volume353,177
30 Day Avg. Volume414,190
Standard Deviation0.16
R-Squared0.14
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.98
Price to Cash Flow (P/CF)10.40
P/FCF Ratio5.30
Enterprise Value/Market Cap1.97
Enterprise Value/Revenue1.93
Enterprise Value/Gross Profit2.95
Enterprise Value/Ebitda24.54
Forecast
1Y Price Target
$22.00Price Target Upside19.83% Upside
Rating ConsensusHold
Number of Analyst Covering3
Embecta Corporation News
PremiumCompany Announcements
Embecta Corp Appoints Anthony Roth as VP and CAO
PremiumCompany Announcements
Embecta Corporation Reports Strong 2024 Financial Results
Bulls Say, Bears Say
Bulls Say
Cost ManagementThe organizational restructuring plan, along with the discontinuation of the patch pump program, is expected to generate annualized pre-tax cost savings of $60-$65M.
Financial PerformanceEmbecta reported an impressive F4Q24 quarter, beating expectations on adjusted revenue, margins and EPS, while setting FY2025 preliminary adj. EBITDA and adj. EPS guidance well ahead of expectations.
Market PositionEmbecta has a strong competitive moat with high-volume device manufacturing capabilities and a global commercial footprint.
Bears Say
Financial PerformanceAdjusted EBITDA missed consensus estimates, indicating a performance shortfall.
Future GuidanceRevenue guidance for 2025 is set below current market expectations, indicating a potential decline in financial performance.
Revenue GrowthThe business seems fairly valued for its cash flow value, indicating limited revenue growth acceleration.
---
Ownership Overview
2.06% Insiders
29.07% Mutual Funds
0.13% Other Institutional Investors
40.84% Public Companies and Individual Investors
EMBC FAQ
What was Embecta Corporation’s price range in the past 12 months?
Embecta Corporation lowest stock price was $9.93 and its highest was $21.48 in the past 12 months.
What is Embecta Corporation’s market cap?
Embecta Corporation’s market cap is $1.10B.
When is Embecta Corporation’s upcoming earnings report date?
Embecta Corporation’s upcoming earnings report date is Feb 18, 2025 which is in 16 days.
How were Embecta Corporation’s earnings last quarter?
Embecta Corporation released its earnings results on Nov 26, 2024. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.362 by $0.088.
Is Embecta Corporation overvalued?
According to Wall Street analysts Embecta Corporation’s price is currently Undervalued.
Does Embecta Corporation pay dividends?
Embecta Corporation pays a Quarterly dividend of $0.6 which represents an annual dividend yield of 3.16%. See more information on Embecta Corporation dividends here
What is Embecta Corporation’s EPS estimate?
Embecta Corporation’s EPS estimate is 0.44.
How many shares outstanding does Embecta Corporation have?
Embecta Corporation has 58,131,760 shares outstanding.
What happened to Embecta Corporation’s price movement after its last earnings report?
Embecta Corporation reported an EPS of $0.45 in its last earnings report, beating expectations of $0.362. Following the earnings report the stock price went up 29.79%.
Which hedge fund is a major shareholder of Embecta Corporation?
Among the largest hedge funds holding Embecta Corporation’s share is Deerfield Management Company, LP. It holds Embecta Corporation’s shares valued at 38M.
---
Embecta Corporation Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$22.00 (19.83% Upside)
$22.00 (19.83% Upside)
Blogger Sentiment
Bullish
EMBC Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 385.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.7%
Last 30 Days ▼ 2.1%
Last 30 Days ▼ 2.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.00%
12-Months-Change
Fundamentals
Return on Equity
-10.61%
Trailing 12-Months
Asset Growth
5.84%
Trailing 12-Months
Company Description
Embecta Corporation
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
---
EMBC Company Deck
---
EMBC Earnings Call
Q4 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
Embecta demonstrated strong execution and financial resilience in a challenging macro environment, including successful debt reduction and product launches. However, significant challenges remain with the discontinuation of the insulin patch pump program and expected pricing headwinds in 2025.Read More>---
EMBC Stock 12 Month Forecast
Average Price Target
$22.00
▲(19.83% Upside)
Technical Analysis
Best Analysts Covering EMBC
1 Year
1 Year Success Rate
5/7 ratings generated profit
1 Year Average Return
+7.59%
assigned a sell rating 2 months ago
Copying Travis Steed's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +7.59% per trade.
---